FDA Considers Japan Scientific Exchange, Expansion of Canada Joint Reviews
This article was originally published in The Gray Sheet
Executive Summary
A meeting between Japanese Ministry of Health and Welfare and Office of Device Evaluation officials tentatively scheduled for October will explore the possibility of a cooperative agreement for sharing premarket review expertise, FDA staffers report.
You may also be interested in...
U.S./Canada Joint Device Review Pilot To Be Expanded to Cardio Devices
FDA and Health Canada plan to release an agreement by the end of October outlining the U.S. and Canadian joint review program's expansion to cardiovascular devices.
U.S./Canada Joint Device Review Pilot To Be Expanded to Cardio Devices
FDA and Health Canada plan to release an agreement by the end of October outlining the U.S. and Canadian joint review program's expansion to cardiovascular devices.
Respiratory Device Hand-off To FDA Dental Group Intended To Achieve Parity
Responsibility for reviewing respiratory device-related premarket submissions is expected to be transferred out of FDA's Division of Cardiovascular and Respiratory Devices (DCRD) to the Division of Dental, Infection Control and General Hospital Use Devices (DDIGD).